Gladius Capital Management LP Taro Pharmaceutical Industries LTD Transaction History
Gladius Capital Management LP
- $99.2 Million
- Q2 2024
A detailed history of Gladius Capital Management LP transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Gladius Capital Management LP holds 761 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
761
Previous 806
5.58%
Holding current value
$0
Previous $34,000
100.0%
% of portfolio
0.0%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding TARO
# of Institutions
16Shares Held
694KCall Options Held
0Put Options Held
0-
Krensavage Asset Management, LLC New York, NY650KShares$012.83% of portfolio
-
Analyst Ims Investment Management Services Ltd.13.6KShares$00.02% of portfolio
-
Credit Suisse Ag Zurich, V813.1KShares$00.0% of portfolio
-
Rhumbline Advisers Boston, MA12.6KShares$00.0% of portfolio
-
Lri Investments, LLC Palm Beach Gardens, FL2KShares$00.01% of portfolio
About TARO PHARMACEUTICAL INDUSTRIES LTD
- Ticker TARO
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 37,584,600
- Description
- Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...